Arcus Biosciences, Inc. — Director's Dealing 2018

Mar 14, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2018-03-14

Reporting Person: KANEKO YASUNORI (Director, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	63130	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Convertible Preferred Stock	$3.96		Common Stock (505050)		Indirect
Series A Convertible Preferred Stock	$3.96		Common Stock (252524)		Indirect
Series B Convertible Preferred Stock	$7.9992		Common Stock (31253)		Indirect
Series C Convertible Preferred Stock	$11.6915		Common Stock (2565)		Indirect

Footnotes

F1: The reported security is convertible into the Issuer's Common Stock on a 1-for-1 basis at any time at the holder's election and shall automatically convert into Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.